Immunological Cross‐Reactivity and Neutralizing Efficacy of Antivenom Against Five Medically Important Iranian Viper Venoms [PDF]
Veterinary Medicine and ScienceBackground Antivenom efficacy relies on the venom antigen composition and the range of antibody cross‐reactivity. This research compared the biochemical profiles of five medically relevant Iranian vipers, Gloydius caucasicus, Pseudocerastes persicus ...
Sedigheh Khamehchian +4 more
doaj +3 more sources
Adverse Reactions After Administration of Antivenom in Korea
Toxins, 2020 Kovax® antivenom is the main treatment for toxins produced by the Gloydius species. However, research on adverse reactions after Kovax® antivenom administration is scarce.
Yongil Cho, Heekyung Lee, Hyunggoo Kang
exaly +4 more sources
An Investigation of Snakebite Antivenom Usage in Taiwan
Journal of the Formosan Medical Association, 2016 Four types of antivenom are used to treat snakebites by the six species of venomous snakes native to Taiwan. Research into antivenom use in Taiwan and its outcomes, as well as the utility of current Taiwan Poison Control Center guidelines for antivenom ...
Chih-Chuan Lin +2 more
exaly +4 more sources
Antivenom Availability, Delays and Use in Australia
Toxicon: X, 2023 Antivenom is the main treatment for snake envenoming and there are ongoing concerns about availability in resource poor regions of the world. However, effective antivenom treatment for snake envenoming requires more than improved availability of safe and
Geoffrey Isbister
exaly +3 more sources
Evaluating Antivenom Efficacy against Echis carinatus Venoms—Screening for In Vitro Alternatives
Toxins, 2022 In India, polyvalent antivenom is the mainstay treatment for snakebite envenoming. Due to batch-to-batch variation in antivenom production, manufacturers have to estimate its efficacy at each stage of IgG purification using the median effective dose ...
Siddharth Bhatia +2 more
doaj +2 more sources
Analysis of factors influencing skin sensitivity test results of antivenom and its potential correlation with allergic reactions: a retrospective cohort study [PDF]
Frontiers in AllergyBackgroundSnakebite remains a persistent public health concern, whether skin sensitivity testing for antivenom should be performed remains a subject of debate.
Haoyu Wang +4 more
doaj +2 more sources
Seroprevalence of Anti-SARS-CoV-2 IgG and IgM Antibodies among Government Employees in Iran [PDF]
Archives of Razi Institute, 2023 The COVID-19 disease emerged in Wuhan, China, in December 2019 and quickly became a global health threat. Around 6,947,192 people have been killed around the world so far, including 146,292 in Iran.
Mohammad Hossein Zabeh Jazi +1 more
doaj +1 more source
Cross-Reactivity and Neutralization Capacity of Polyspecific Antivenom Produced by Razi Institute against Three Species of Buthidea Family Scorpions [PDF]
Asia Pacific Journal of Medical Toxicology, 2019 Background: Scorpion sting is a significant health problem in southern provinces of Iran. Many thousands of people are stung by different species of scorpions annually. More than 60 scorpion species have been reported to be present in Iran. However, Razi
Bahzad Masihipour +4 more
doaj +1 more source
Frontiers in Medicine, 2022 BackgroundVenom-induced consumption coagulopathy (VICC) is an important clinical consequence of Russell’s viper (Daboia russelii) envenoming. There is limited evidence for antivenom effectiveness in resolving VICC.
Anjana Silva +8 more
doaj +1 more source
First Case Report of an Unusual Echis genus (Squamata: Ophidia: Viperidae) Body Pattern Design in Iran [PDF]
Archives of Razi Institute, 2019 Three families of venomous snakes exist in Iran including Viperidae, Elapidae, and Hydrophidae. Viperidae family is the only family with a widespread distribution. Saw-scaled vipers are important poisonous snakes in Asia and Africa. This name is given to
S. Navidpour +2 more
doaj +1 more source